Compounds > 4,5,6,7-tetrabromo-2-azabenzimidazole
Page last updated: 2024-10-21

4,5,6,7-tetrabromo-2-azabenzimidazole and Biliary Tract Cancer

4,5,6,7-tetrabromo-2-azabenzimidazole has been researched along with Biliary Tract Cancer in 1 studies

4,5,6,7-tetrabromobenzotriazole: a CK2 kinase inhibitor

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wachter, J1
Neureiter, D1
Alinger, B1
Pichler, M1
Fuereder, J1
Oberdanner, C1
Di Fazio, P1
Ocker, M1
Berr, F1
Kiesslich, T1

Other Studies

1 other study available for 4,5,6,7-tetrabromo-2-azabenzimidazole and Biliary Tract Cancer

ArticleYear
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
    International journal of biological sciences, 2012, Volume: 8, Issue:1

    Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line,

2012